Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Divanmedicin AB
AB
Active
Org 5567317101
Orrstigen 3, 182 35
Danderyd
General medical practice activities
·
NACE 8621
Est. 2007 · 19 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
General medical practice activities
/
Divanmedicin AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
4M
3M
2M
1M
0M
2021: 2M
2M
2021
2022: 3M (+50% vs 2021)
3M
+50%
2022
2023: 3M (0% vs 2022)
3M
0%
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: 3M (0% vs 2024)
3M
0%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 1M
1M
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
3 078
3 100
2 692
2 636
2 081
Staff expenses
−1 611
−1 514
−1 393
—
—
EBITDA
417
840
458
406
291
Depreciation & amort.
−181
−174
−153
−149
−149
EBIT
235
666
305
257
142
Net financials
286
312
337
185
176
Profit before tax
464
1 058
642
505
319
Tax
−36
−157
−69
−62
−30
Net profit
428
900
573
443
289
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
7 193
6 997
5 537
4 747
4 945
Equity
5 113
4 914
4 104
3 731
3 637
Long-term debt
737
997
408
45
305
Short-term debt
1 036
835
696
642
674
Total debt
1 773
1 832
1 104
687
979
Financial ratios
5-year trend
EBITDA margin
13,5 %
This company
15,8 %
Market median
This company
Market median
15% below market
2021
2025
Equity ratio
71,1 %
This company
38,2 %
Market median
This company
Market median
86% above market
2021
2025
Return on equity
8,4 %
This company
18,4 %
Market median
This company
Market median
54% below market
2021
2025
Net profit margin
13,9 %
This company
8,1 %
Market median
This company
Market median
72% above market
2021
2025
Asset turnover
0,43×
This company
1,12×
Market median
This company
Market median
62% below market
2021
2025
Debt / equity
0,41×
This company
0,62×
Market median
This company
Market median
34% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on Divanmedicin AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
